Trial intelligence / Profile preview

R21/Matrix-M1 malaria vaccine safety and immunogenicity study in healthy adults in Burkina Faso

PACTR201610001813366Unknown

Sponsor
University of Oxford
Start
Aug 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Trial of R21/Matrix-M in malaria (3 arms), sponsored by University of Oxford. Status: unknown.

02

Drugs

R21/Matrix-M
03

Conditions

malaria

Beyond the preview

Go deeper on PACTR201610001813366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201610001813366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call